Gliotoxin reduces the severity of trinitrobenzene sulfonic scid-induced colitis in mice: Evidence of the connection between heme oxygenase-1 and the nuclear factor-κB pathway in vitro and in vivo

Inflammatory Bowel Diseases

Volumn 12, Issue 7, 2006, Pages 619-629

  Jun, Chang Duk ^a   Kim, Yurim ^b   Choi, Eun Yong ^b   Kim, Minsun ^b   Park, Byungrim ^b   Youn, Byungsoo ^b   Yu, Kangyeol ^b   Choi, Kyu Sil ^b   Yoon, Kwon Ha ^b   Choi, Suck Chei ^b   Lee, Myeung Su ^b   Park, Kie In ^c   Choi, Minkyu ^a   Chung, Yeuntai ^a   Oh, Jaemin ^a,b  

^a Gwangju Institute of Science and Technology (GIST)   (South Korea)

^b Wonkwang University   (South Korea)

^c Chonbuk National University   (South Korea)

Author keywords

Gliotoxin; Heme oxygenase 1; Inflammatory bowel diseases; Nuclear factor B; Trinitrobenzene sulfonic acid

Indexed keywords

GLIOTOXIN; HEME OXYGENASE 1; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 8; MYELOPEROXIDASE; PROTOPORPHYRIN ZINC; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BODY WEIGHT; CELL STRAIN HT29; COLITIS; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BODY WEIGHT; CACO-2 CELLS; COLITIS; GLIOTOXIN; HEME OXYGENASE-1; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-8; MICE; NF-KAPPA B; PEROXIDASE; TRINITROBENZENESULFONIC ACID; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33745573362     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/01.ibd.0000225340.99108.8a     Document Type: Article

References (34)

1. Sugimoto K, Hanai H, Tozawa K, et al. Curcumin prevents and ameliorates trinitrobenzene sulfonic acid-induced colitis in mice. Gastroenterology. 2002;123:1912-1922.
2. Hanauer SB. Inflammatory bowel disease. N Engl J Med. 1996;334:841-848.
3. Sutton P, Newcombe NR, Waring P, et al. In vivo immunosuppressive activity of gliotoxin, a metabolite produced by human pathogenic fungi. Infect Immun. 1994;62:1192-1198.
4. Waring P, Eichner RD, Mullbacher A, et al. Gliotoxin induces apoptosis in macrophages unrelated to its antiphagocytic properties. J Biol Chem. 1988;263:18493-18499.
5. Pahl HL, Krauss B, Schulze-Osthoff K, et al. The immunosuppressive fungal metabolite gliotoxin specifically inhibits transcription factor NF-kappaB. J Exp Med. 1996;183:1829-1840.
6. Ward C, Chilvers ER, Lawson MF, et al. NF-kappaB activation is a critical regulator of human granulocyte apoptosis in vitro. J Biol Chem. 1999;274:4309-4318.
7. Kroll M, Arenzana-Seisdedos F, Bachelerie F, et al. The secondary fungal metabolite gliotoxin targets proteolytic activities of the proteasome. Chem Biol. 1999;6:689-698.
8. Hamamoto N, Maemura K, Hirata I, et al. Inhibition of dextran sulphate sodium (DSS)-induced colitis in mice by intracolonically administered antibodies against adhesion molecules (endothelial leucocyte adhesion molecule-1 (ELAM-1) or intercellular adhesion molecule-1 (ICAM-1). Clin Exp Immunol. 1999;117:462-468.
9. Neurath MF, Pettersson S, Meyer zum Buschenfelde KH, et al. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med. 1996;2:998-1004.
10. Fitzpatrick LR, Wang J, Le T. In vitro and in vivo effects of gliotoxin, a fungal metabolite: efficacy against dextran sodium sulfate-induced colitis in rats. Dig Dis Sci. 2000;45:2327-2336.
11. Fitzpatrick LR, Wang J, Le T. Gliotoxin, an inhibitor of nuclear factor-kappa B, attenuates peptidoglycan-polysaccharide-induced colitis in rats. Inflamm Bowel Dis. 2002;8:159-167.
12. Herfarth H, Brand K, Rath HC, et al. Nuclear factor-kappa B activity and intestinal inflammation in dextran sulphate sodium (DSS)-induced colitis in mice is suppressed by gliotoxin. Clin Exp Immunol. 2000;120:59-65.
13. Rosenberg DW, Kappas A. Characterization of heme oxygenase in the small intestinal epithelium. Arch Biochem Biophys. 1989;274:471-480.
14. Cable JW, Cable EE, Bonkovsky HL. Induction of heme oxygenase in intestinal epithelial cells: studies in Caco-2 cell cultures. Mol Cell Biochem. 1993;129:93-98.
15. Maines MD. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J. 1988;2:2557-2568.
16. Tamaki T, Konoeda Y, Yasuhara M, et al. Glutamine-induced heme oxygenase-1 protects intestines and hearts from warm ischemic injury. Transplant Proc. 1999;31:1018-1019.
17. Christodoulides N, Durante W, Kroll MH, et al. Vascular smooth muscle cell heme oxygenases generate guanylyl cyclase-stimulatory carbon monoxide. Circulation. 1995;91:2306-2309.
18. Iyer S, Woo J, Cornejo MC, et al. Characterization and biological significance of immunosuppressive peptide D2702.75-84(E -(V) binding protein. Isolation of heme oxygenase-1. J Biol Chem. 1998;273:2692-2697.
19. Ben Trivedi A, Kitabatake N, Doi E. Toxicity of dimethyl sulfoxide as a solvent in bioassay system with HeLa cells evaluated colorimetrically with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide. Agric Biol Chem. 1990;54:2961-2966.
20. Vilaseca J, Salas A, Guarner F, et al. Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis. Gut. 1990;31:539-544.
21. Keyse SM, Tyrrell RM. Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc Natl Acad Sci U S A. 1989;86:99-103.
22. Soares MP, Seldon MP, Gregoire IP, et al. Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation. J Immunol. 2004;172:3553-3563.
23. Rogler G, Andus T. Cytokines in inflammatory bowel disease. World J Surg. 1998;22:382-389.
24. Lee JI, Burckart GJ. Nuclear factor kappa B: important transcription factor and therapeutic target. J Clin Pharmacol. 1998;38:981-993.
25. Lopez-Franco O, Suzuki Y, Sanjuan G, et al. Nuclear factor-kappa B inhibitors as potential novel anti-inflammatory agents for the treatment of immune glomerulonephritis. Am J Pathol. 2002;161:1497-1505.
26. Vogt BA, Shanley TP, Croatt A, et al. Glomerular inflammation induces resistance to tubular injury in the rat. A novel form of acquired, heme oxygenase-dependent resistance to renal injury. J Clin Invest. 1996;98:2139-2145.
27. Laniado-Schwartzman M, Abraham NG, Conners M, et al. Heme oxygenase induction with attenuation of experimentally induced corneal inflammation. Biochem Pharmacol. 1997;53:1069-1075.
28. Wang WP, Guo X, Koo MW, et al. Protective role of heme oxygenase-1 on trinitrobenzene sulfonic acid-induced colitis in rats. Am J Physiol Gastrointest Liver Physiol. 2001;281:G586-G594.
29. Lakics V, Medvedev AE, Okada S, et al. Inhibition of LPS-induced cytokines by Bcl-xL in a murine macrophage cell line. J Immunol. 2000;165:2729-2737.
30. Muller K, Dulku S, Hardwick SJ, et al. Changes in vimentin in human macrophages during apoptosis induced by oxidised low density lipoprotein. Atherosclerosis. 2001;156:133-144.
31. Lee HJ, Lee JH, Hwang BY, et al. Anti-angiogenic activities of gliotoxin and its methylthioderivative, fungal metabolites. Arch Pharm Res. 2001;24:397-401.
32. Lavrovsky Y, Schwartzman ML, Levere RD, et al. Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene. Proc Natl Acad Sci U S A. 1994;91:5987-5991.
33. Wahl C, Liptay S, Adler G, et al. Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B. J Clin Invest. 1998;101:1163-1174.
34. Maity S, Ukil A, Karmakar S, et al. Thearubigin, the major polyphenol of black tea, ameliorates mucosal injury in trinitrobenzene sulfonic acid-induced colitis. Eur J Pharmacol. 2003;470:103-112.